Background In order to improve injury assessment of brain injuries, protein markers of
pathophysiological processes and tissue fate have been introduced in the clinic. The most …

Objectives To determine the ability and accuracy of the S-100β protein in predicting
prognosis after a moderate or severe traumatic brain injury. Design Systematic review and …

Ninety percent of patients with minor head injury (MHI) who have cranial computed
tomography (CCT) under the present clinical decision rules have normal scans. Serum …

STUDY OBJECTIVE: A computed tomography (CT) scan has high sensitivity in detecting
intracranial injury in patients with minor head injury but is costly, exposes patients to high …

The objective of the study was to examine how S100B, a biomarker of traumatic brain injury
(TBI), contributes to outcome prediction after adjusting for known parameters, including age …

Protein S-100B is released into the circulation after traumatic brain injury, and its serum
concentration relates to measures of injury severity and outcome. These properties have led …

Neuron-specific enolase (NSE) and S100B protein have been shown to be increased in
cerebrospinal fluid (CSF) and serum of patients suffering from subarachnoid hemorrhage …

S100B is a calcium-binding protein released into the blood from astroglial cells due to brain
injury. Some authors have described a correlation between S100B serum concentration and …

Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in adults and
children. Predicting outcome after TBI is difficult, but it is important for acute management …

Purpose: There is growing evidence that S-100B protein may be used as a novel
biochemical marker of brain cell damage, measured by a simple blood test. In this paper, we …